CARY, N.C., Feb. 08, 2017 -- Arysta LifeScience recently announced that it has entered into a global collaboration with DuPont Crop Protection for the development of new foliar insecticides based on the market-leading product, DuPont™ Rynaxypyr® (chlorantraniliprole). The long-term agreement between the two companies allows Arysta LifeScience to combine Rynaxypyr® insect control in premixes with acetamiprid, thereby creating novel insecticidal formulations that more efficiently and conveniently address needs of growers.
“Through our collaboration with DuPont, we are expanding our development of proprietary foliar insecticides for specialty crop protection,” said Diego Lopez Casanello, president, Arysta LifeScience. “The premix formulations will control a broader spectrum of pests than straight Rynaxypyr® products, which will increase its utility to growers in many countries around the world.”
“Our agreement with Arysta LifeScience increases the value of our investment in Rynaxypyr®, and most importantly, gives growers more tools to effectively manage insects,” said Timothy P. Glenn, president, DuPont Crop Protection.
Combining Rynaxypyr® with acetamiprid offers multiple benefits including:
- Broadening the spectrum of control of Rynaxypyr® with activity on sucking pests such as whiteflies, aphids, certain lepidoptera, and micro-lepidoptera
- Fit with a broad range of crop segments, including both row and specialty crops
- Offering flexible application timing suitable for integrated pest management
- Controlling pests that have become resistant to other products
About Arysta LifeScience
Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company’s wide range of offerings includes biosolutions, fungicides, herbicides, insecticides and seed treatments. Arysta LifeScience, which has more than 4,000 employees working in over 100 countries to serve customers worldwide, had 2015 revenues of US$1.8 billion. Arysta LifeScience is owned by Platform Specialty Products (www.platformspecialtyproducts.com), a global innovator of technologically advanced specialty chemical products and provider of technical services. For more information on Arysta LifeScience, visit www.arystalifescience.com.
Media Contact: Carey Dorman Director – Corporate Development Platform Specialty Products Corporation 1-561-406-8465


BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 



